SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120871
Filing Date
2016-05-13
Accepted
2016-05-13 16:01:26
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6686_110q.htm 10-Q 533695
2 EX-31.1 a16-6686_1ex31d1.htm EX-31.1 11896
3 EX-31.2 a16-6686_1ex31d2.htm EX-31.2 11898
4 EX-32.1 a16-6686_1ex32d1.htm EX-32.1 5201
5 EX-32.2 a16-6686_1ex32d2.htm EX-32.2 5232
  Complete submission text file 0001104659-16-120871.txt   3200945

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ctrv-20160331.xml EX-101.INS 544207
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctrv-20160331.xsd EX-101.SCH 40556
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctrv-20160331_cal.xml EX-101.CAL 25027
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctrv-20160331_def.xml EX-101.DEF 166931
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ctrv-20160331_lab.xml EX-101.LAB 335758
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctrv-20160331_pre.xml EX-101.PRE 258446
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36856 | Film No.: 161648250
SIC: 2834 Pharmaceutical Preparations